These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29317077)

  • 1. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years.
    Bergasa NV
    Med Hypotheses; 2018 Jan; 110():86-89. PubMed ID: 29317077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TGR5 receptor mediates bile acid-induced itch and analgesia.
    Alemi F; Kwon E; Poole DP; Lieu T; Lyo V; Cattaruzza F; Cevikbas F; Steinhoff M; Nassini R; Materazzi S; Guerrero-Alba R; Valdez-Morales E; Cottrell GS; Schoonjans K; Geppetti P; Vanner SJ; Bunnett NW; Corvera CU
    J Clin Invest; 2013 Apr; 123(4):1513-30. PubMed ID: 23524965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.
    Lieu T; Jayaweera G; Zhao P; Poole DP; Jensen D; Grace M; McIntyre P; Bron R; Wilson YM; Krappitz M; Haerteis S; Korbmacher C; Steinhoff MS; Nassini R; Materazzi S; Geppetti P; Corvera CU; Bunnett NW
    Gastroenterology; 2014 Dec; 147(6):1417-28. PubMed ID: 25194674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pruritus of cholestasis: from bile acids to opiate agonists.
    Jones EA; Bergasa NV
    Hepatology; 1990 May; 11(5):884-7. PubMed ID: 2161397
    [No Abstract]   [Full Text] [Related]  

  • 5. The pruritus of cholestasis.
    Bergasa NV
    Semin Dermatol; 1995 Dec; 14(4):302-12. PubMed ID: 8679436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pruritus of cholestasis is relieved by an opiate antagonist: is this pruritus a centrally mediated phenomenon?
    Heathcote J
    Hepatology; 1996 May; 23(5):1280-2. PubMed ID: 8621166
    [No Abstract]   [Full Text] [Related]  

  • 7. The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids.
    Bergasa NV; Jones EA
    Gastroenterology; 1995 May; 108(5):1582-8. PubMed ID: 7729651
    [No Abstract]   [Full Text] [Related]  

  • 8. Mediators of pruritus during cholestasis.
    Oude Elferink RP; Kremer AE; Beuers U
    Curr Opin Gastroenterol; 2011 May; 27(3):289-93. PubMed ID: 21451412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pruritus in chronic cholestatic liver disease.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2012 May; 16(2):331-46. PubMed ID: 22541702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal artificial liver support systems in the management of intractable cholestatic pruritus.
    Fuhrmann V; Drolz A; Trauner M
    Liver Int; 2011 Sep; 31 Suppl 3():31-3. PubMed ID: 21824282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis.
    Jones EA; Bergasa NV
    Can J Gastroenterol; 2000 Jan; 14(1):33-40. PubMed ID: 10655025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated.
    Nelson L; Vergnolle N; D'Mello C; Chapman K; Le T; Swain MG
    J Hepatol; 2006 Jun; 44(6):1141-9. PubMed ID: 16466825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling.
    Cipriani S; Renga B; D'Amore C; Simonetti M; De Tursi AA; Carino A; Monti MC; Sepe V; Zampella A; Fiorucci S
    PLoS One; 2015; 10(7):e0129866. PubMed ID: 26177448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and Treating Pruritus in Primary Biliary Cholangitis.
    Carrion AF; Rosen JD; Levy C
    Clin Liver Dis; 2018 Aug; 22(3):517-532. PubMed ID: 30259850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.
    Davis M
    Clin Pharmacokinet; 2007; 46(10):825-50. PubMed ID: 17854233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.
    Jones EA; Neuberger J; Bergasa NV
    QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Characterization of a Novel Mouse Model of Cholestatic Pruritus.
    Andoh T; Suzuki K; Konno M; Tsuneyama K; Kuraishi Y
    Biol Pharm Bull; 2020; 43(7):1111-1117. PubMed ID: 32612073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pruritus in liver disease. Pathogenesis and treatment].
    Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
    Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting FXR in cholestasis: hype or hope.
    Fiorucci S; Distrutti E; Ricci P; Giuliano V; Donini A; Baldelli F
    Expert Opin Ther Targets; 2014 Dec; 18(12):1449-59. PubMed ID: 25200104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis and treatment of pruritus and fatigue in patients with PBC.
    Jones EA; Bergasa NV
    Eur J Gastroenterol Hepatol; 1999 Jun; 11(6):623-31. PubMed ID: 10418933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.